Close Menu

NEW YORK (GenomeWeb) – Paradigm Diagnostics said today that it has closed a $15 million Series B fundraising, which has been ongoing since 2017. In conjunction with the closing, the firm has added Mara Aspinall, managing director of BlueStone Venture Partners, to its board of directors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.